Tocopherol inhibits the relaxing effect of terbutaline in the respiratory and reproductive tracts of the rat: The role of the oxidative stress index

The Effects of Female Sexual Hormones on the Expression of Aquaporin 5 in the Late-Pregnant Rat Uterus

“…The compounds were dissolved in olive oil. The animals were injected subcutaneously with 1 µg/0.1 mL of 17β-estradiol [35,36], 5 mg/0.1 mL of tamoxifen citrate [37], and 1 mg/0.1 mL of clomiphene citrate [38,39] once a day for four days. On day 18 and 22, the uterine samples were collected and the molecular studies were carried out.…”

“…These hormones were dissolved in olive oil and injected subcutaneously every day in a dose of 0.5 mg/0.1 mL of progesterone [35,36] and levonorgestrel [40], and 5 mg/0.1 mL of medroxyprogesterone acetate [41] for seven days. On day 18 and 22, the uterine samples were collected, and the molecular studies were carried out.…”

The effects of female sexual hormones on α1- and α2- adrenergic receptor subtypes in the pregnant rat myometrium

“…E2 was dissolved in olive oil. The animals were injected subcutaneously with 5 μg/kg of E2 once a day for 4 days (Hódi et al 2014).…”

The role of the aquaporin 5 in the function of late pregnant rat uterus: pharmacological studies

“…The pretreatment of pregnant animals with 17β-estradiol valerate, tamoxifen citrate, and clomiphene citrate (Sigma-Aldrich, Budapest, Hungary) was started on day 14 and day 18 of gestation. The active agents were suspended in olive oil and injected subcutaneously in a dose of 1 µg/0.1 ml of 17β-estradiol (Bóta et al, 2015;Hódi et al, 2014); 5 mg/0.1 ml of tamoxifen citrate (Cyr, 2000); and 1 mg/0.1 ml of clomiphene citrate (Bharti et al, 2013;Nutu et al, 2010) once a day for four days. On day 18 and the last day of pregnancy, day 22, the uterine samples were collected and molecular studies were carried out.…”

“…The animals were injected subcutaneously every day with 0.5 mg/0.1 ml of progesterone and levonorgestrel, and 5 mg/0.1ml of medroxyprogesterone acetate for seven days. (Bóta et al, 2015;Brandon and Raval, 1979;Graham and Milad, 2013;Hódi et al, 2014) On day 18 and 22, the uterine samples were collected and molecular studies were carried out. We chose these durations for the hormonal treatments according to our earlier investigations.…”